This is not the most recent version of the article. View current version (19 JUL 2006)

Intervention Protocol

Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts

  1. B Ratilal,
  2. J Costa,
  3. C Sampaio

Editorial Group: Cochrane Anaesthesia Group

Published Online: 20 JUL 2005

DOI: 10.1002/14651858.CD005365


How to Cite

Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts (Protocol). The Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD005365. DOI: 10.1002/14651858.CD005365.

Author Information

*Dr Bernardo Ratilal, Resident in Neurosurgery, Department of Neurosurgery, São José Hospital, Rua José António Serrano, Lisboa, Lisbon, 1150-199, PORTUGAL. bratilal@yahoo.com.

Publication History

  1. Published Online: 20 JUL 2005

SEARCH

This is not the most recent version of the article. View current version (19 JUL 2006)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

We will examine the following hypotheses:

(1) the incidence of shunt infection is less frequent with administration of systemic antibiotics beginning previously or at the time of the surgical procedure;

(2) the incidence of shunt infection is less frequent when antibiotic-impregnated shunt systems are used, considering that the eventual regimen of systemic antibiotics applied is the same.

We will perform separate analyses for systemic antibiotics and antibiotic-impregnated systems.

To test these hypotheses a literature review with the following objectives will be carried out:

Primary objective

We will establish the effectiveness and safety of the use of prophylactic antibiotics, whether systemic or catheter-impregnated, for intracranial ventricular shunts. We will separately analyse external and internal intracranial shunts.

Secondary Objectives

If sufficient relevant information is available, we will perform the following subgroup analysis:

(1) to determine the differences in infectious risk of external ventricular shunts versus internal ventricular shunts;
(2) to determine the differences in infectious risk of ventriculoperitoneal shunts versus ventriculoatrial shunts;
(3) to determine the differences in infectious risk in children versus adults (above 18 years old);
(4) to determine the differences in infectious risk in using periprocedural antibiotics versus continuous antibiotics.